Coeptis Therapeutics Holdings, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$862K
R&D↓-9.0% -$31K
$313K
D&A↑+18.0% +$45K
$295K
Operating Income↓-15.7% -$335K
$-2M
EBITDA↑+18.0% +$45K
$295K
Interest Expense↑+22.9% +$12K
$63K
Interest Income
—
Other Income/Expense↓-198.7% -$723K
$-359K
Pretax Income↓-58.5% -$1M
$-3M
Tax Provision
$0
Net Income↓-58.5% -$1M
$-3M
Operating Margin
-1043.2%
Net Margin
-1220.8%
Effective Tax Rate↑+0.0pts
0.0%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+2.3pts
24.9%
ETR State + Local (pp)↓-2.6pts
-3.1%
Operating Lease Cost↑+1.0% +$110
$12K
Income YoY Variation↓-88.5pts
-15.7%
Revenue QoQ Variation
263.1%
Income QoQ Variation↑+20.9pts
45.2%